Primary hyperoxaluria types 1 and 2 : Not only a pediatric disease;Prïmare Hyperoxalurie Typ 1 und 2 : Eine nicht nür padiatrische Erkrankung

Nephrologe

Volumn 3, Issue 2, 2008, Pages 118-127

  Kemper, M J ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Citrate; Combined liver kidney transplantation; Hyperoxaluria; Nephrocalcinosis; Pre emptive liver transplantation; Primary hyperoxaluria types 1 and 2; Urolithiasis

Indexed keywords

EID: 40249116248     PISSN: 1862040X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11560-007-0142-7     Document Type: Article

References (29)

1. 1. Basmaison 2000 Hum Mutat 15 577 10862087 10.1002/1098-1004(200006)15:6<577::AID-HUMU9>3.0.CO;2-# 1:STN:280:DC%2BD3cvhtFSlug%3D%3D Basmaison O, Rolland MO, Cochat P, Bozon D (2000) Identification of 5 novel mutations in the AGXT gene. Hum Mutat 15: 577
2. 2. Behnke 2001 Nephrol Dial Transplant 16 2236 11682674 10.1093/ndt/16.11.2236 1:CAS:528:DC%2BD3MXptVykurY%3D Behnke B, Kemper MJ, Kruse HP, Müller-Wiefel DE (2001) Bone mineral density in children with primary hyperoxaluria type I. Nephrol Dial Transplant 16: 2236–2239
3. 3. Cochat 1995 Nephrol Dial Transplant 3 Cochat P, Deloraine A, Rotily M et al. (1995) Epidemiology of primary hyperoxaluria type 1. Société de Nephrologie and the Société de Nephrologie Pédiatrique. Nephrol Dial Transplant (Suppl 8) 10: 3–7
4. 4. Cochat 1999 J Pediatr 135 746 10586179 10.1016/S0022-3476(99)70095-8 1:STN:280:DC%2BD3c%2FlsVKiuw%3D%3D Cochat P, Koch Nogueira PC, Mahmoud MA et al. (1999) Primary hyperoxaluria in infants: medical, ethical, and economic issues. J Pediatr 135: 746–750
5. 5. Cregeen 2003 Hum Mutat 22 497 14635115 10.1002/humu.9200 1:CAS:528:DC%2BD2cXps1Ok Cregeen DP, Williams EL, Hulton S, Rumsby G (2003) Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2. Hum Mutat 22: 497
6. 6. Danpure 1996 Ann N Y Acad Sci 804 477 8993566 10.1111/j.1749-6632.1996.tb18638.x 1:CAS:528:DyaK2sXhtVehu7s%3D Danpure CJ, Jennings PR, Leiper JM et al. (1996) Targeting of alanine: glyoxylate aminotransferase in normal individuals and its mistargeting in patients with primary hyperoxaluria type 1. Ann N Y Acad Sci 804: 477–490
7. 7. Danpure 1987 Lancet 1 289 2880111 10.1016/S0140-6736(87)92023-X 1:STN:280:DyaL2s7hsVCmuw%3D%3D Danpure CJ, Jennings PR, Watts RW (1987) Enzymological diagnosis of primary hyperoxaluria type 1 by measurement of hepatic alanine: glyoxylate aminotransferase activity. Lancet 1: 289–291
8. 8. Giafi 1998 Ann Clin Biochem 35 104 9463747 1:CAS:528:DyaK1cXpslKrsQ%3D%3D Giafi CF, Rumsby G (1998) Kinetic analysis and tissue distribution of human D-glycerate dehydrogenase/glyoxylate reductase and its relevance to the diagnosis of primary hyperoxaluria type 2. Ann Clin Biochem 35: 104–109
9. 9. Hoppe 1996 Pediatr Nephrol 10 488 8865249 10.1007/s004670050145 1:STN:280:DyaK2s%2FhvVKgsQ%3D%3D Hoppe B, Graf D, Offner G et al. (1996) Oxalate elimination via hemodialysis or peritoneal dialysis in children with chronic renal failure. Pediatr Nephrol 10: 488–492
10. 10. Hoppe 1998 Kidney Int 54 921 9734617 10.1046/j.1523-1755.1998.00066.x 1:STN:280:DyaK1cvgtlKrtA%3D%3D Hoppe B, Kemper MJ, Bokenkamp A, Langman CB (1998) Plasma calcium-oxalate saturation in children with renal insufficiency and in children with primary hyperoxaluria. Kidney Int 54: 921–925
11. 11. Hoppe 1999 Kidney Int 56 268 10411702 10.1046/j.1523-1755.1999.00546.x 1:CAS:528:DyaK1MXksVyjsr0%3D Hoppe B, Kemper MJ, Bokenkamp A et al. (1999) Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure. Kidney Int 56: 268–274
12. 12. Hoppe 2005 Am J Nephrol 25 276 15961947 10.1159/000086358 Hoppe B, Latta K, Schnakenburg C von, Kemper MJ (2005) Primary hyperoxaluria–the German experience. Am J Nephrol 25: 276–281
13. 13. Jamieson 2005 Am J Nephrol 25 282 15961948 10.1159/000086359 Jamieson NV (2005) A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): The European PH1 transplant registry experience 1984–2004. Am J Nephrol 25: 282–289
14. 14. Kemper 2005 Pediatr Transplant 9 693 16269037 10.1111/j.1399-3046.2005.00362.x Kemper MJ (2005) Concurrent or sequential liver and kidney transplantation in children with primary hyperoxaluria type 1? Pediatr Transplant 9: 693–696
15. 15. Kemper 2005 Urol Res 33 376 16284878 10.1007/s00240-005-0495-1 Kemper MJ (2005) The role of preemptive liver transplantation in primary hyperoxaluria type 1. Urol Res 33: 376–379
16. 16. Kemper 1997 Eur J Pediatr 156 509 9243228 10.1007/s004310050649 1:STN:280:DyaK2szoslWltw%3D%3D Kemper MJ, Conrad S, Müller-Wiefel DE (1997) Primary hyperoxaluria type 2. Eur J Pediatr 156: 509–512
17. 17. Kopp 1995 Nephrol Dial Transplant 10 2224 8808215 1:STN:280:DyaK28vgtl2gtQ%3D%3D Kopp N, Leumann E (1995) Changing pattern of primary hyperoxaluria in Switzerland. Nephrol Dial Transplant 10: 2224–2227
18. 18. Latta 1990 Eur J Pediatr 149 518 2189732 10.1007/BF01957682 1:STN:280:DyaK3c3mvFartw%3D%3D Latta K, Brodehl J (1990) Primary hyperoxaluria type I. Eur J Pediatr 149: 518–522
19. 19. Leumann 2001 J Am Soc Nephrol 12 1986 11518794 1:STN:280:DC%2BD3MvnsFeqsQ%3D%3D Leumann E, Hoppe B (2001) The primary hyperoxalurias. J Am Soc Nephrol 12: 1986–1993
20. 20. Leumann 1995 Nephrol Dial Transplant 14 Leumann E, Hoppe B, Neuhaus T, Blau N (1995) Efficacy of oral citrate administration in primary hyperoxaluria. Nephrol Dial Transplant (Suppl 8) 10: 14–16
21. 21. Marangella 1995 Kidney Int 48 182 7564076 10.1038/ki.1995.283 1:STN:280:DyaK28%2Fit1ygtA%3D%3D Marangella M, Vitale C, Petrarulo M et al. (1995) Bony content of oxalate in patients with primary hyperoxaluria or oxalosis-unrelated renal failure. Kidney Int 48: 182–187
22. 22. Monico 2005 Kidney Int 67 1704 15840016 10.1111/j.1523-1755.2005.00267.x 1:CAS:528:DC%2BD2MXktlOqur8%3D Monico CG, Rossetti S, Olson JB, Milliner DS (2005) Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele. Kidney Int 67: 1704–1709
23. 23. Monico 2007 J Am Soc Nephrol 18 1905 17460142 10.1681/ASN.2006111230 1:CAS:528:DC%2BD2sXnt1WjsLY%3D Monico CG, Rossetti S, Schwanz HA et al. (2007) Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis. J Am Soc Nephrol 18: 1905–1914
24. 24. Nolkemper 2000 Pediatr Transplant 4 177 10933316 10.1034/j.1399-3046.2000.00107.x 1:STN:280:DC%2BD3M%2FlsFOrtw%3D%3D Nolkemper D, Kemper MJ, Burdelski M et al. (2000) Long-term results of pre-emptive liver transplantation in primary hyperoxaluria type 1. Pediatr Transplant 4: 177–181
25. 25. Rinat 1999 J Am Soc Nephrol 10 2352 10541294 1:CAS:528:DyaK1MXnsVegsL0%3D Rinat C, Wanders RJ, Drukker A et al. (1999) Primary hyperoxaluria type I: a model for multiple mutations in a monogenic disease within a distinct ethnic group. J Am Soc Nephrol 10: 2352–2358
26. 26. Toussaint 1993 Am J Kidney Dis 21 54 8418628 1:STN:280:DyaK3s7hvVKlsw%3D%3D Toussaint C, De Pauw L, Vienne A et al. (1993) Radiological and histological improvement of oxalate osteopathy after combined liver-kidney transplantation in primary hyperoxaluria type 1. Am J Kidney Dis 21: 54–63
27. 27. Van 1996 Kidney Int 50 1747 10.1038/ki.1996.494 Van Acker KJ, Eyskens FJ, Espeel MF et al. (1996) Hyperoxaluria with hyperglycoluria not due to alanine: glyoxylate aminotransferase defect: a novel type of primary hyperoxaluria. Kidney Int 50: 1747–1752
28. 28. Webster 2000 Mol Urol 4 355 11156703 1:CAS:528:DC%2BD3MXlvVCi Webster KE, Cramer SD (2000) Genetic basis of primary hyperoxaluria type II. Mol Urol 4: 355–364
29. 29. Williams 2006 Am J Kidney Dis 48 481 16931222 10.1053/j.ajkd.2006.05.022 1:CAS:528:DC%2BD28XhtVCmtrbE Williams EL, Kemper MJ, Rumsby G (2006) A de novo mutation in the AGXT gene causing primary hyperoxaluria type 1. Am J Kidney Dis 48: 481–483